Literature DB >> 11353645

Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

F Fitoussi1, C Loukil, I Gros, O Clermont, P Mariani, S Bonacorsi, I Le Thomas, D Deforche, E Bingen.   

Abstract

Macrolide susceptibility was investigated in clinical group B streptococci obtained from neonates or pregnant women in 2000 in France. Of 490 consecutive isolates, 18% were resistant to erythromycin. The erm(B), erm(A) subclass erm(TR), and mef(A) genes were harbored by 47, 45, and 6% of these strains, respectively. Two isolates did not harbor erm or mef genes.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11353645      PMCID： PMC90565          DOI： 10.1128/AAC.45.6.1889-1891.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

Authors:  V D Shortridge; G V Doern; A B Brueggemann; J M Beyer; R K Flamm
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.

Authors:  F Depardieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

4.  Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.

Authors:  E L Palavecino; I Riedel; X Berrios; S Bajaksouzian; D Johnson; E Kaplan; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.

Authors:  G J Tyrrell; L D Senzilet; J S Spika; D A Kertesz; M Alagaratnam; M Lovgren; J A Talbot
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

6.  Macrolide resistance in Belgian Streptococcus pneumoniae.

Authors:  K Lagrou; W E Peetermans; J Verhaegen; S Van Lierde; L Verbist; J Van Eldere
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

7.  Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

Authors:  A Tait-Kamradt; T Davies; M Cronan; M R Jacobs; P C Appelbaum; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors:  F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

9.  Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.

Authors:  A Tait-Kamradt; T Davies; P C Appelbaum; F Depardieu; P Courvalin; J Petitpas; L Wondrack; A Walker; M R Jacobs; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

10.  Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Authors:  J I Andrews; D J Diekema; S K Hunter; P R Rhomberg; M A Pfaller; R N Jones; G V Doern
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661
View more
  19 in total

1.  Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.

Authors:  Daniel J Diekema; Janet I Andrews; Holly Huynh; Paul R Rhomberg; Stella R Doktor; Jill Beyer; Virginia D Shortridge; Robert K Flamm; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.

Authors:  Ziya Cibali Acikgoz; Ebru Almayanlar; Sohret Gamberzade; Safiye Gocer
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

3.  Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.

Authors:  V Lavergne; M Laverdière; A Duchesne; C Béliveau; J Delorme; A Di Zazzo; A C Labbé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

4.  Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay.

Authors:  Xianyu Zeng; Fanrong Kong; Hui Wang; Archie Darbar; Gwendolyn L Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

Authors:  M A De Francesco; S Caracciolo; F Gargiulo; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-26       Impact factor: 3.267

7.  Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.

Authors:  James S Lewis; Alex J Lepak; George R Thompson; William A Craig; David R Andes; Kathryn E Sabol-Dzintars; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

8.  Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae.

Authors:  Young Uh; Hyo Youl Kim; In Ho Jang; Gyu Yel Hwang; Kap Jun Yoon
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

10.  Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors:  A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-28       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.